China Pharma Holdings
CPHI
7 hedge funds and large institutions have $73.8K invested in China Pharma Holdings in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
63% more capital invested
Capital invested by funds: $45.4K → $73.8K (+$28.5K)
40% more funds holding
Funds holding: 5 → 7 (+2)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 0.05% → 0.04% (-0.02%)
Top Buyers
| 1 |
Millennium Management
New York
|
+$20.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$18.6K |
| 3 |
JP Morgan Chase
New York
|
+$7.34K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.85K |
| 5 |
HF
HRT Financial
New York
|
+$2.36K |
Top Sellers
| 1 |
TSS
Two Sigma Securities
New York
|
-$9.01K |
| 2 |
VF
Virtu Financial
New York
|
-$7.87K |
| 3 |
Renaissance Technologies
New York
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $33.6K | +$20.3K | +3,625 | +187% |
|
|
2
Citadel Advisors
Miami,
Florida
| $20.1K | +$18.6K | +3,324 | New |
|
|
3
JP Morgan Chase
New York
| $7.92K | +$7.34K | +1,308 | New |
|
|
VF
4
Virtu Financial
New York
| $6K | -$7.87K | -1,402 | -60% |
|
|
5
UBS Group
Zurich,
Switzerland
| $4.15K | +$3.85K | +686 | New |
|
|
HF
6
HRT Financial
New York
| $2K | +$2.36K | +421 | New |
|
|
FCT
7
First Community Trust
Dubuque,
Iowa
| $18 | – | – | – |
|
|
TSS
8
Two Sigma Securities
New York
| – | -$9.01K | -1,217 | Closed |
|
|
9
Renaissance Technologies
New York
| – | -$5K | -619 | Closed |
|
CPHI Hedge Fund Activity: Q4 2023 in Review
7 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2023, worth a combined $73.8K — up 63% from $45.4K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CPHI positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Millennium Management, adding an estimated $20.3K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $9.01K sold.
- 7 institutional investors held China Pharma Holdings (CPHI) as of Q4 2023, up from 5 in Q3 2023.
- Funds reported $73.8K of China Pharma Holdings stock for Q4 2023, up 63% quarter-over-quarter.
- 4 funds opened new China Pharma Holdings positions in Q4 2023 and 2 closed out, a net change of +2 holders.
- The largest China Pharma Holdings buyer in Q4 2023 was Millennium Management, an estimated $20.3K added.
- The largest China Pharma Holdings seller in Q4 2023 was Two Sigma Securities, an estimated $9.01K sold.
Based on aggregated 13F filings for Q4 2023.